ABSTRACT… Pleural effusion is the one of the most common clinical conditions encountered in pulmonology clinics and the routinely performed tests on pleural fluid do not provide definitive diagnosis in majority of the cases. Medical thoracoscopy with pleural biopsy under direct vision of the abnormal area provides the highest diagnostic yield. Abrams closed needle pleural biopsy is a conventional and cheaper procedure which can help in the definitive diagosis in cases of undiagnosed pleural effusion. To determine the diagnostic yield of abrams pleural biopsy in patients presenting with lymphocytic exudative pleural effusion. Study Design: Cross Sectional Study. Setting: Department of Pulmonology Nishtar Hospital Multan; Tertiary care hospital of 1180 beds. Period: Six months. Materials and Methods: There were 145 patients diagnosed with lymphocytic exudative pleural effusion. Results: Of these 145 study cases, males were 83/145 (57.2%) whereas females were 62/145 (42.8%). Mean age of our patients was 41.62 ± 13.63 years while mean duration of illness was 7.0 ± 3.24 weeks. When the frequencies of various diagnosis established on the basis of histopathology results obtained from the tissue specimen obtained with Abrams pleural biopsy was noted, Tuberculosis was the major cause of lymphocytic exudative pleural effusion as its frequency was noted to be in 81/145 (55.9%) of our patients while malignancy was present in 26/145 (17.9%) of our study cases whereas the histopathology turned out to be inconclusive in 38/145 (26.2%) showing non-specific inflammation. The diagnostic yield of Abrams pleural biopsy turned out to be 73.8% whereas it was unable to establish diagnosis in 26.2%. Conclusion: Abrams needle pleural biopsy is simple, reliable and safe method of diagnosis with a good diagnostic yield. Routine use of this procedure in patients with lymphocytic exudative pleural effusion can lead to a definitive diagnosis in majority of patients.
INTRODUCTION
Pleural effusion is a frequently encountered problem in respiratory clinics and despite advances in the cytological, biochemical and microbiological tests which are done on the pleural fluid the etiological diagnosis cannot be established in majority of patients, which are then labelled as undiagnosed exudative pleural effusions. 1 Prevailing causes of lymphocytic exudative pleural effusions include malignancy, tuberculosis, connective tissue diseases, sarcoidosis and sometimes pulmonary embolism. 2, 3, 4 Pleural fluid cytology in malignant pleural effusion turns out to be positive in 40%-80% of the cases and pleural fluid culture for acid fast bacilli is positive in less than 40% cases of tuberculous effusions. When closed pleural biopsy is performed with histological examination and culture of the obtained pleural tissue the diagnostic yield for tuberculosis increases to 80 to 90%. 5 This signifies that closed pleural biopsy plays an important role in differentiating tuberculous from malignant pleural effusion.
A Study conducted by Ihsanullah in Pakistan has
shown pleural biopsy to be conclusive in 95% cases which include 56.7% for TB and 40% for malignancy. 6 In two other national studies pleural biopsy showed positive results in 71.62%, and 63.29% of cases that include 52.71%, and 42% for TB whereas 18.91%, and 36% for malignancy respectively.
A study conducted by Gupta et al. in India established that out of 48 cases, results of closed pleural biopsy were conclusive in 62.2% of cases. Of these 43.8% revealed Tuberculosis, 29.2% Malignancy, 12.5% Paramalignant. 8 Patients with lymphocytic exudative type of pleural effusion are a common presentation in tertiary care hospitals. Pakistan being endemic country for tuberculosis, most of such patients are given antituberculous therapy without confirmation of diagnosis. However differential diagnosis includes malignancy, autoimmune disorders, etc. In order to rationalize our management we intend to look into the role of pleural biopsy using Abram's pleural biopsy needle. Various studies have shown high yield of pleural biopsy using Abram needle in suspected tuberculous pleural effusions, however in malignant pleural effusion, its yield is moderate. Patients who remain undiagnosed on this procedure need further diagnostic workup using medical pleuroscopy or video assisted thoracoscopic (VATS) pleural biopsy. However these relatively advanced procedures are only available in few centers of Pakistan and a number of patients remain undiagnosed due to either lack of facility for pleuroscopic biopsies or lack of expertise.
We are conducting this study to assess the diagnostic yield of Abrams pleural biopsy as there is no data available in our local setup. 
MATERIALS AND METHODS

Data Collection Procedure
One hundred and forty five (145) consecutive patients with diagnosed Lymphocytic exudative effusion attending the Pulmonology indoor and outpatient department were included in the study. Permission was taken from institutional ethical committee to conduct this study. Written Informed consent was taken from patients after thoroughly explaining the procedure. Those patients who fulfilled the inclusion and exclusion criteria closed pleural biopsy was performed with full aseptic measures and under local anesthesia by the researcher. Closed pleural biopsy was done with Abrams needle to obtain 3-4 biopsy samples. The samples were properly labeled and sent in formalin jar to Shaukat Khanam Laboratory for histopathological examination. All the demographic data and results of histopathology were noted in the proforma.
RESULTS
There were 145 patients diagnosed with lymphocytic exudative pleural effusion. Of these 145 study cases, males were 83/145 (57.2%) whereas females were 62/145 (42.8%) ( Figure-1 ). Mean age of our patients was 41.62 ± 13.63 years (minimum 18 to maximum 66 years). Mean duration of illness was 7.0 ± 3.24 weeks (minimum 3 weeks to maximum 14 weeks). (Figure-2) . The diagnostic yield of Abrams pleural biopsy turned out to be 73.8% whereas it was unable to establish diagnosis in 26.2%. (Figure-3 
DISCUSSION
Lymphocytic exudative pleural effusion is a common clinical problem in respiratory medicine clinics all over the world. Conclusive diagnosis of the cause of lymphocytic exudative pleural effusion is a challenging problem which requires a number of costly investigations done on pleural fluid with a relatively low diagnostic yield. In such patients pleuroscopy with pleural biopsy under direct vision is recommended to reach a definite diagnosis. However, the invasiveness, cost, requirement of expertise and sterilization as well as unavailability of the equipment limits its use in resource limited settings. Alternatively, blind Pleural biopsy can be performed in such patients which can provide a definite tissue diagnosis. This procedure has been used routinely in the past before the advent of fiber-optic pleuroscopes. Its use is now considered out-dated because the diagnostic yield of blind closed pleural biopsy is reported to be significantly lower than that can be achieved with pleuroscopic biopsy.
It requires careful evaluation for tuberculosis, malignancy (i.e. lung cancer, lymphoma, and metastasis) and some uncommon diseases like sarcoidosis etc. It is usually treated empirically with anti-TB treatment but considering the increasing incidence of malignancies especially lung cancer definitive diagnosis should always be considered. In patients aged over 60 years, malignant diseases should be considered the most probable cause, although reactivation of previous TB may also present as lymphocytic exudative Pleural effusion.
9,14,15
Our study comprised of a total of 145 patients diagnosed with lymphocytic exudative pleural effusion males were 83/145 (57.2%) whereas females were 62/145 (42.8%). Various authors have reported that lymphocytic exudative pleural effusion being more common among male patients than females. Ihsanullah reported 74 % male patients and 26% female patients. 6 Rehan et al 10 reported 65 % male patients with pleural effusion and 35 % female patients, these findings are close to that of our study results.
Mean age of our study cases was 41.62 ± 13.63 years (minimum age was 18 years and maximum age was 66 years). Similar results have been reported by Ihsanullah et al. 6 Rehan et al 10 reported mean age of pleural effusion patients to be 44.82 ± 17.71 years, which is close to our study results. 10 reported dyspnea frequency as 82% (which was predominant as well), this value is close to our findings, however in our study fever was leading presenting complaint which was 80 % as reported by Rehan et al. 10 Rehan et al reported that 77 % of their patients presenting with cough which is also similar to our study results. Ihsanullah et al 12 reported similar findings.
In majority of our study cases, pleural effusion was seen on the right side i.e. 89 (61.4%) while it was on the left side 56 (38.6%) of our study cases. Similar findings have been reported by Ihsanullah. 6 Rehan et al 10 58 % on the right side and 30 % on the left side, these findings are close to that of our study results.
Diagnostic yield of the Abrams needle pleural biopsy among targeted population has been reported to be variable ranging from below 60% to as high as 95 % of the patients. 6 Our study results report the diagnostic yield to be 73.8% which are close to the diagnostic yield reported by Rajawat et al which was 71.2%.
11
Tuberculosis was the major cause of lymphocytic exudative pleural effusion as its frequency was noted in 81/145 (55.9%) of our study cases while malignancy was present in 26/145 (17.9%) of our study cases. Similar findings have been reported by many different researchers in which TB was the major cause of exudative lymphocytic pleural effusion. 6, 7, 10, 12, 13 Our study results are in compliance with most of the national and international studies which also reported a good diagnostic yield of the procedure and TB being leading cause of pleural effusion.
CONCLUSION
Abrams needle pleural biopsy in lymphocytic exudative pleural effusion is simple, reliable and safe method of diagnosis with diagnostic yield in majority of the cases as observed in our study. Tuberculosis was the leading cause of pleural effusion in our study. Copyright© 25 Mar, 2019.
